KNSA — Kiniksa Pharmaceuticals
Median target
$90
calls from the last 12 months
Implied return
-3.5%
median target vs. price
Coverage
9 analysts · 10 calls
updated in the last 12 months
Consensus
9/0/0+9 net
Buy / Hold / Sell
Which analysts are behind KNSA's consensus?
See every current rating, price target and the analysts' track records for Kiniksa Pharmaceuticals — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 9 analysts with calls on KNSA updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
KNSA elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-11-03 | Insiders | Patel Sanj KCHAIRMAN & CEO | Insider sale | 145.7K sh @ $93.53 · planned trade | $13.6M |
| 2026-11-03 | Insiders | Patel Sanj KCHAIRMAN & CEO | Insider sale | 68.7K sh @ $92.70 · planned trade | $6.4M |
| 2026-11-03 | Insiders | Patel Sanj KCHAIRMAN & CEO | Insider sale | 4.6K sh @ $94.25 · planned trade | $432K |
| 2026-11-03 | Insiders | Patel Sanj KCHAIRMAN & CEO | Insider sale | 1.2K sh @ $90.77 · planned trade | $110K |
| 2026-11-02 | Insiders | Patel Sanj KCHAIRMAN & CEO | Insider sale | 38.4K sh @ $91.03 · planned trade | $3.5M |
| 2026-11-02 | Insiders | Patel Sanj KCHAIRMAN & CEO | Insider sale | 26.8K sh @ $93.06 · planned trade | $2.5M |
| 2026-11-02 | Insiders | Patel Sanj KCHAIRMAN & CEO | Insider sale | 24.2K sh @ $91.83 · planned trade | $2.2M |
| 2026-11-02 | Insiders | Paolini John F.CHIEF MEDICAL OFFICER | Insider sale | 16.8K sh @ $93.42 · planned trade | $1.6M |
| 2026-11-02 | Insiders | Ragosa MarkCHIEF FINANCIAL OFFICER | Insider sale | 14.0K sh @ $91.40 · planned trade | $1.3M |
| 2026-11-02 | Insiders | Ragosa MarkCHIEF FINANCIAL OFFICER | Insider sale | 12.0K sh @ $93.13 · planned trade | $1.1M |
More: insider activity · executive branch · trending